metastatic castration-resistant prostate cancer

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

metastatic castration-resistant prostate cancer
May 24, 2025, 19:13 | Drugs
Amol Akhade on ODAC’s unanimous vote against Talazoparib + Enzalutamide for non-HRRm mCRPC
Amol Akhade, Consultant Medical Oncologist at the Suyog Cancer Clinics, shared a post on LinkedIn:…
May 22, 2025, 08:35 | Science
Dillon Cockrell: Targeted Therapy for mCRPC with BRCA Mutations
Dillon Cockrell, Medical Oncologist and GU Cancer Expert at Duke Cancer Center, shared an article on…
May 18, 2025, 03:53 | Science
Galip Can Uyar: What Drives Decision Regret in Older Men with mCRPC?
Galip Can Uyar, Medical Oncologist at Etlik City Hospital, shared an article on X: "New in…
May 8, 2025, 10:41 | Blog
Updated Guideline on Systemic Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer - ASCO
American Society of Clinical Oncology (ASCO) shared a post on LinkedIn: "We issued a guideline update…
May 7, 2025, 03:49 | Science
Rohan Garje: The Updated ASCO Guidelines on Metastatic Castration-Resistant Prostate Cancer
Rohan Garje, Associate Professor and Chief of Genitourinary Medical Oncology at Miami Cancer Institue, shared an…
Apr 22, 2025, 13:59 | Blog
The systemic therapy options available for mCRPC - National Comprehensive Cancer Network
National Comprehensive Cancer Network (NCCN) shared a post on LinkedIn: "Join us on April 28 for…
Mar 24, 2025, 10:41 | Science
Immune Checkpoint Combinations in mCRPC, by Dr. Susan Slovin
Ravi A Madan, Clinical researcher at the National Cancer Institute, shared an article by Susan…
Nov 27, 2024, 19:54 | Insight
Shahrin Ahmed: Advanced prostate cancer with genetic mutations can be improved by combination therapy
Shahrin Ahmed, Medical specialist in oncology at the Canadian Cancer Society, shared a post on…
Oct 19, 2024, 18:47 | Blog
Hannah Dzimitrowicz McManus: Navigating therapeutic sequencing in the mcRPC
Hannah Dzimitrowicz McManus, Hematology-Oncology Fellow at Duke University Health System, shared a recent article on…
Sep 16, 2024, 10:25 | Societies
The efficacy benefits of radioisotopes in metastatic castration-resistant prostate cancer - ESMO
ESMO shared on LinkedIn: "At ESMO24, Late-Breaking Abstracts provide evidence for the efficacy benefits of…
May 19, 2024, 09:46 | Blog
June 1 issue of ACS Journal Cancer
ACS Journal Cancer shared a post on X: “Read our June 1 issue! In this issue:…
May 8, 2024, 07:21 | Insight
Umang Swami: Prior NHT in patients with MCRPC
Umang Swami, Assistant Professor in the Department of Oncology at Huntsman Cancer Institute, shared on…
Feb 29, 2024, 14:42 | Insight
Researchers at Dana-Farber Cancer Institute and the University of Trento have developed a blood test that can reliably detect NEPC and differentiate it from CRPC-adenocarcinoma - Dana-Farber Cancer Institute
Jan 14, 2024, 14:49 | Blog
Chris Boshoff: The European Medicines Agency approved our Prostate Cancer combination for men living with metastatic castration-resistant prostate cancer
Chris Boshoff, Chief Oncology Officer and Executive Vice President at Pfizer, shared on LinkedIn: "I’m proud…
All: 14 Posts: 1 - 100
Special Coverage